A quantitative structure-activity relationship study on a novel class of calcium-entry blockers: 1-[(4-(aminoalkoxy)phenyl)sulphonyl]indolizines.

A quantitative structure-activity relationship (QSAR) study has been made on two different series of 1-[(4-(aminoalkoxy)phenyl)sulphonyl]indolizines acting as calcium entry blockers, using some physicochemical and structural parameters. Two different assays were reported for both the series: (IC(50))(A), referring to the molar concentration of the compound required to reduce [3H] nitrendipine binding by 50%, and (IC(50))(B), referring to that required to block Ca(2+) induced concentration of K(+) depolarised rat aorta by 50%. For series 1, where the 2-position substituents of indolizine ring were varied along with the aminoalkoxy moieties of the phenyl ring, the QSAR analysis shows that the 2-position substituents can equally affect both the activities through their hydrophobic and electronic properties and the aminoalkoxy moiety through some steric effects. For series 2, where the indolizine ring has been replaced by varying heterocyclic rings, along with the changes in aminoalkoxy moiety of the phenyl ring, the QSAR exhibits that these different heterocyclic rings affect both the activities through some steric roles, altering the conformations of the receptors from system A to system B. Among the different heterocyclic rings, the N-substituted indole ring is shown to be more conducive to both the activities than any other ring. However, a 5-membered ring is indicated to be less effective than a 9- or 10-membered ring for activity B. Additionally, the amino moieties having phenyl ring with methoxy groups at 3,4,and 5-positions are shown to favour both A and B activities.

[1]  A Hedberg,et al.  Active conformation of 1,4-dihydropyridine calcium entry blockers. Effect of size of 2-aryl substituent on rotameric equilibria and receptor binding. , 1991, Journal of medicinal chemistry.

[2]  P. Polster,et al.  A novel class of calcium-entry blockers: the 1[[4-(aminoalkoxy)phenyl]sulfonyl]indolizines. , 1992, Journal of medicinal chemistry.

[3]  Rongan Zhang,et al.  Calcium entry blockers and activators: conformational and structural determinants of dihydropyrimidine calcium channel modulators. , 1995, Journal of medicinal chemistry.

[4]  F. Bossert,et al.  4‐Aryldihydropyridines, a New Class of Highly Active Calcium Antagonists , 1981 .

[5]  M. Botta,et al.  Diltiazem-like calcium entry blockers: a hypothesis of the receptor-binding site based on a comparative molecular field analysis model. , 1997, Journal of medicinal chemistry.

[6]  C. Romming,et al.  Crystal structures and pharmacological activity of calcium channel antagonists: 2,6-dimethyl-3,5-dicarbomethoxy-4-(unsubstituted, 2-methyl-, 4-methyl-, 3-nitro-, 4-nitro-, and 2,4-dinitrophenyl)-1,4-dihydropyridine. , 1982, Journal of medicinal chemistry.

[7]  S. Moreland,et al.  Studies directed toward ascertaining the active conformation of 1,4-dihydropyridine calcium entry blockers. , 1988, Journal of medicinal chemistry.

[8]  L B Kier,et al.  General definition of valence delta-values for molecular connectivity. , 1983, Journal of pharmaceutical sciences.

[9]  H. Glossmann,et al.  Identification of the benzothiazepine-binding polypeptide of skeletal muscle calcium channels with (+)-cis-azidodiltiazem and anti-ligand antibodies. , 1990, The Journal of biological chemistry.

[10]  L. Hall,et al.  Molecular connectivity in chemistry and drug research , 1976 .

[11]  A. M. Triggle,et al.  Characterization of binding of the Ca++ channel antagonist, [3H]nitrendipine, to guinea-pig ileal smooth muscle. , 1983, The Journal of pharmacology and experimental therapeutics.

[12]  A. Leo,et al.  Substituent constants for correlation analysis in chemistry and biology , 1979 .

[13]  P. Polster,et al.  Novel heterocyclic analogues of the new potent class of calcium entry blockers: 1-[[4-(aminoalkoxy)phenyl]sulfonyl]indolizines. , 1993, Journal of medicinal chemistry.